Venture Life Group plc (LON:VLG – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 44.28 ($0.56) and traded as low as GBX 40 ($0.50). Venture Life Group shares last traded at GBX 40.45 ($0.51), with a volume of 130,101 shares changing hands.
Venture Life Group Stock Performance
The stock has a market capitalization of £51.46 million, a P/E ratio of 4,050.00, a P/E/G ratio of 5.67 and a beta of 0.30. The company’s 50-day moving average is GBX 44.28 and its two-hundred day moving average is GBX 44.14. The company has a current ratio of 2.22, a quick ratio of 1.48 and a debt-to-equity ratio of 28.45.
Insiders Place Their Bets
In related news, insider Mark Adams purchased 116,496 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were bought at an average cost of GBX 43 ($0.54) per share, for a total transaction of £50,093.28 ($63,129.53). Also, insider Gianluca Braguti sold 77,930 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of GBX 46 ($0.58), for a total transaction of £35,847.80 ($45,176.81). 10.41% of the stock is owned by insiders.
About Venture Life Group
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids.
Further Reading
- Five stocks we like better than Venture Life Group
- What is the Dow Jones Industrial Average (DJIA)?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Energy and Oil Stocks Explained
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.